ANA MARIN: Open Payments
NPI 1699257162 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 25 payments from 13 companies in 2025. Trend: 2023 $461 · 2024 $397 · 2025 $1,041
Food & beverage: $942Education: $99
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 6 | $345 |
| Bolton Medical Inc | 1 | $147 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $97 |
| Boston Scientific Corporation | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $60 |
| Abbott Laboratories | 2 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| PFIZER INC. | 2 | $44 |
| BridgeBio Pharma, Inc. | 1 | $33 |
Products named: UPTRAVI, TREO ABDOMINAL STENT-GRAFT SYSTEM, OPSUMIT, LifeVest, Kerendia, General - Therapies, CAMZYOS, VYNDAQEL.
Industry payments across FL — which companies pay providers there.
